Kafka et al. [70] revealed that DVL3, TCF1, and LEF1 expression significantly increased with astrocytoma malignancy grades, suggesting their cooperation with nuclear β-catenin and joint involvement in malignant progression. This evidence concerns the gene LEF1 and astrocytoma (excluding glioblastoma).